Analyst Reco. LeMaitre Vascular, Inc.

Equities

LMAT

US5255582018

Real-time Estimate Cboe BZX Other stock markets 07:36:26 01/05/2024 pm IST			5-day change	1st Jan Change
65.48 ^USD	+1.05%		+2.08%	+15.15%

29/04	North American Morning Briefing : Investors Brace -2-	DJ
26/04	Stifel Upgrades LeMaitre Vascular to Buy From Hold, Adjusts Price Target to $75 From $59	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Stifel Upgrades LeMaitre Vascular to Buy From Hold, Adjusts Price Target to $75 From $59	26/04	MT
Barrington Raises Price Target on LeMaitre Vascular to $69 From $66, Keeps Outperform Rating	28/02	MT
JMP Securities Initiates LeMaitre Vascular With Market Outperform Rating, Price Target is $60	23/23/23	MT
Oppenheimer Initiates Coverage on LeMaitre Vascular With Outperform Rating, $70 Price Target	06/23/06	MT
Jefferies Downgrades LeMaitre Vascular to Hold From Buy, Adjusts Price Target to $67 From $63	03/23/03	MT
Barrington Raises Price Target on LeMaitre Vascular to $66 From $62, Maintains Outperform Rating	02/23/02	MT
Stifel Raises LeMaitre Vascular's Price Target to $60 From $48, Hold Rating Kept	03/23/03	MT
Jefferies Raises LeMaitre Vascular's Price Target to $63 From $57, Maintains Buy Rating	03/23/03	MT
Roth MKM Raises LeMaitre Vascular's Price Target to $54 From $48, Neutral Rating Kept	03/23/03	MT
Barrington Research Upgrades LeMaitre Vascular to Outperform From Market Perform	03/23/03	MT
Barrington Research Downgrades LeMaitre Vascular to Market Perform From Outperform	28/22/28	MT
Barrington Lowers LeMaitre Vascular's Price Target to $50 From $54, Maintains Outperform Rating	29/22/29	MT
Barrington Research Trims LeMaitre Vascular's Price Target to $54 From $62, Maintains Outperform Rating	25/22/25	MT
Barrington Adjusts Price Target on LeMaitre Vascular to $62 From $64, Maintains Outperform Rating	29/21/29	MT
LEMAITRE VASCULAR : Jefferies Initiates LeMaitre Vascular at Buy Rating With $70 Price Target	16/21/16	MT
LEMAITRE VASCULAR : Roth Capital Adjusts LeMaitre Vascular's Price Target to $58 from $55, Keeps Neutral Rating	03/21/03	MT
LEMAITRE VASCULAR : Barrington Adjusts Price Target on LeMaitre Vascular to $64 From $59, Maintains Outperform Rating	30/21/30	MT
LEMAITRE VASCULAR : Roth Capital Adjusts LeMaitre Vascular PT to $55 From $53, Maintains Neutral Rating	04/21/04	MT
LEMAITRE VASCULAR : Barrington Adjusts Price Target on LeMaitre Vascular to $59 From $49, Maintains Outperform Rating	01/21/01	MT
LEMAITRE VASCULAR : Barrington Adjusts LeMaitre Vascular PT to $49 From $47, Maintains Outperform Rating	26/21/26	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. LeMaitre Vascular, Inc.

Equities

LMAT

US5255582018

Analyst Reco.

Filters